Ocular Therapeutix is dedicated to the development and commercialization of therapeutic ophthalmic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology.

Drug-eluting punctum plugs are investigational new drugs and not commercially available in the United States.

ReSure Sealant is an investigational device that is currently under
clinical evaluation and is not commercially available in the United States.